Mosby's 2014 Nursing Drug Reference (173 page)

BOOK: Mosby's 2014 Nursing Drug Reference
6.02Mb size Format: txt, pdf, ePub

 

Controlled Substance Schedule II

Do not confuse:
fentaNYL
/Sufenta

ACTION:

Inhibits ascending pain pathways in CNS, increases pain threshold, alters pain perception by binding to opiate receptors

USES:

Controls moderate to severe pain; preoperatively, postoperatively; adjunct to general anesthetic, adjunct to regional anesthesia;
FentaNYL:
anesthesia as premedication, conscious sedation;
Actiq:
breakthrough cancer pain

CONTRAINDICATIONS:

Hypersensitivity to opiates, myasthenia gravis

 

Black Box Warning:

Headache, migraine (Actiq, ABSTRAL, Fentora, Lazanda, Onsolis); emergency room use (ABSTRAL, Lazanda); outpatient surgeries (Duragesic TD); opioid-naive patients, respiratory depression

Precautions:
Pregnancy (C), breastfeeding, geriatric patients, increased intracranial pressure, seizure disorders, severe respiratory disorders, cardiac dysrhythmias

 

Black Box Warning:

Accidental exposure, ambient temperature increase, fever, skin abrasion (TD patch), substance abuse, surgery, requires an experienced clinician

DOSAGE AND ROUTES
Calculator
Fentanyl
Anesthetic

• Adult:
IV
50-100 mcg/kg over 1-2 min

Anesthesia supplement

• Adult and child >12 yr:
IM/IV
2-20 mcg/kg
IV INF
0.025-0.25 mcg/kg/min

Induction and maintenance

• Child 2-12 yr:
IV
2-3 mcg/kg

Preoperatively

• Adult and child >12 yr:
IM/IV
50-100 mcg q30-60min before surgery

Postoperatively

• Adult and child >12 yr:
IM/IV
0.05-0.1 mg q1-2hr prn

Moderate/severe pain

• Adult:
IV/IM
50-100 mcg q1-2hr

Actiq

• Adult:
TRANSMUCOSAL
200 mcg; redose if needed 15 min after completion of 1st dose; do not give more than 2 doses during titration period, max 4 doses/day

Fentora

• Adult:
BUCCAL
100 mcg placed above rear molar between upper cheek and gum, a second 100 mcg dose, if needed, may be started 30 min after 1st dose

Onsolis

• Adult:
TRANSMUCOSAL
200 mcg, titrate, max 1200 mcg/dose or 4 doses/day

ABSTRAL

• Adult:
SL
100 mcg; another dose may be taken 30 min after 1st, max 2 doses per episode of breakthrough pain; ≥2 hr must elapse before treating again; titrate stepwise over consecutive episodes

FentaNYL transdermal

• Adult:
25 mcg/hr; may increase until pain relief occurs; apply patch to flat surface on upper torso and wear for 72 hr; apply new patch on different site for continued relief

FentaNYL nasal spray

• Adult:
100 mcg (1 spray in 1 nostril), may retreat after ≥2 hr, titrate upward until adequate analgesia; treat a max of 4 episodes daily

FentaNYL SL spray

• Adult:
100 mcg sprayed under tongue, titrate stepwise carefully

Available forms:
Inj 0.05 mg/ml; lozenges 100, 200, 300, 400, 600, 800, 1200, 1600 mcg; lozenges on a stick 200, 400, 600, 800, 1200, 1600 mcg; buccal tab 100, 200, 400, 600, 800 mcg; oral dissolving film (Onsolis) 200, 400, 600, 800, 1200 mcg; SL tab (ABSTRAL) 100, 200, 300, 400, 600, 800 mcg;
transdermal:
patch 12, 25, 50, 75, 100 mcg/hr;
SL spray:
100, 200, 400, 600, 800, 1200, 1600 mcg/spray

Administer:

• 
By inj (IM, IV); give slowly to prevent rigidity

• 
Must have emergency equipment available, opioid antagonists, O
2
; to be used only by those appropriately trained; IV products to be used in OR, ER, ICU

Transmucosal route

• 
Remove foil just before administration; instruct patient to place product between cheek and lower gum, moving it back and forth and sucking, not chewing (Actiq); place above rear molar (Fentora); place film on the inside of the cheek (Onsolis); all products not used or only partially used should be flushed down the toilet

Transdermal route

• 
q72hr for continuous pain relief; dosage adjusted after at least 2 applications; apply to clean, dry skin and press firmly

• 
Give short-acting analgesics until patch takes effect (8-24 hr); when reducing dosage or switching to alternative IV treatment, withdraw gradually; serum levels drop gradually, give 1/2 the equian
algesic dose of new analgesic 12-18 hr after removal as ordered

SL spray

• 
Open blister package with scissors immediately before use; spray contents of unit under tongue; dispose of each used unit after use by placing it into one of the disposable bags provided; seal bag, discard into a trash container out of reach of children

IV route

• 
IV undiluted by anesthesiologist or diluted with 5 ml or more sterile water or 0.9% NaCl given through
Y
-tube or 3-way stopcock at 0.1 mg or less/1-2 min. Muscular rigidity may occur with rapid IV administration

Additive compatibilities:
Bupivacaine, caffeine citrate, cloNIDine, droperidol, EPINEPHrine, ketamine, lidocaine, ziconotide

Solution compatibilities:
D
5
W, 0.9% NaCl

Syringe compatibilities:
Alprostadil, atracurium, atropine, bupivacaine/ketamine, butorphanol, chlorproMAZINE, cimetidine, cloNIDine/lidocaine, diphenhyDRINATE, diphenhydrAMINE, droperidol, heparin, HYDROmorphone, hydrOXYzine, lidocaine, meperidine, metoclopramide, midazolam, morphine, pentazocine, perphenazine, prochlorperazine, promazine, promethazine, ranitidine, scopolamine

Y-site compatibilities:
Abciximab, acyclovir, alfentanil, alprostadil, amikacin, aminocaproic acid, aminophylline, amiodarone, amphotericin B cholesteryl, amphotericin B lipid complex, amphotericin B liposome, anidulafungin, argatroban, ascorbic acid injection, atenolol, atracurium, atropine, azathioprine, aztreonam, benztropine, bivalirudin, bleomycin, bumetanide, buprenorphine, butorphanol, calcium chloride/gluconate, CARBOplatin, caspofungin, cefamandole, ceFAZolin, cefmetazole, cefonicid, cefoperazone, cefotaxime, cefoTEtan, cefOXitin, cefTAZidime, ceftizoxime, ceftobiprole, cefTRIAXone, cefuroxime, cephalothin, chloramphenicol, chlorproMAZINE, cimetidine, cisatracurium, CISplatin, clindamycin, cloNIDine, cyanocobalamin, cyclophosphamide, cycloSPORINE, cytarabine, DACTINomycin, DAPTOmycin, dexamethasone, dexmedetomidine, digoxin, diltiazem, diphenhydrAMINE, DOBUTamine, DOCEtaxel, DOPamine, doripenem, doxacurium, doxapram, DOXOrubicin, doxycycline, enalaprilat, ePHEDrine, EPINEPHrine, epirubicin, epoetin alfa, eptifibatide, erythromycin, esmolol, etomidate, etoposide, famotidine, fenoldopam, fluconazole, fludarabine, fluorouracil, folic acid, furosemide, ganciclovir, gatifloxacin, gemcitabine, gentamicin, glycopyrrolate, granisetron, heparin, hydrocortisone, HYDROmorphone, hydrOXYzine, IDArubicin, ifosfamide, imipenem-cilastatin, inamrinone, insulin (regular), irinotecan, isoproterenol, ketorolac, labetalol, lansoprazole, levofloxacin, lidocaine, linezolid, LORazepam, LR, magnesium sulfate, mannitol, mechlorethamine, meperidine, metaraminol, methicillin, methotrexate, methotrimeprazine, methoxamine, methyldopate, methylPREDNISolone, metoclopramide, metoprolol, metroNIDAZOLE, mezlocillin, miconazole, midazolam, milrinone, minocycline, mitoXANtrone, mivacurium, morphine, moxalactam, multiple vitamins injection, mycophenolate, nafcillin, nalbuphine, naloxone, nesiritide, netilmicin, niCARdipine, nitroglycerin, nitroprusside, norepinephrine, octreotide, ondansetron, oxacillin, oxaliplatin, oxytocin, PACLitaxel, palonosetron, pamidronate, pancuronium, papaverine, PEMEtrexed, penicillin G potassium/sodium, pentamidine, pentazocine, PENTobarbital, PHENobarbital, phenylephrine, phytonadione, piperacillin, piperacillin-tazobactam, polymyxin B, potassium chloride, procainamide, prochlorperazine, promethazine, propofol, propranolol, protamine, pyridoxine, quiNIDine, quinupristin-dalfopristin, ranitidine, remifentanil, Ringer’s, ritodrine, riTUXimab, rocuronium, sargramostim, scopolamine, sodium acetate/bicarbonate, succinylcholine, SUFentanil,
tacrolimus, teniposide, theophylline, thiamine, thiopental, thiotepa, ticarcillin, ticarcillin-clavulanate, tigecycline, tirofiban, TNA, tobramycin, tolazoline, TPN, trastuzumab, trimetaphan, urokinase, vancomycin, vasopressin, vecuronium, verapamil, vinCRIStine, vinorelbine, vitamin B complex/C, voriconazole, zoledronic acid

SIDE EFFECTS

CNS:
Dizziness, delirium, euphoria, sedation

CV:
Bradycardia, arrest,
hypo/hypertension

EENT:
Blurred vision, miosis

GI:
Nausea, vomiting, constipation

GU:
Urinary retention

INTEG:
Rash, diaphoresis

MS:
Muscle rigidity

RESP:
Respiratory depression, arrest, laryngospasm

PHARMACOKINETICS

Metabolized by liver, excreted by kidneys, crosses placenta, excreted in breast milk, Half-life: IV: 2-4 hr, Transdermal: 13-22 hr, Transmucosal: 7 hr, Buccal: 4-12 hr, 80% bound to plasma proteins

IM:
Onset 7-8 min, peak 30 min, duration 1-2 hr

IV:
Onset 1 min, peak 3-5 min, duration 1/2-1 hr

INTERACTIONS

 

Black Box Warning:

Increase:
fentaNYL effect, fetal respiratory depression: (cycloSPORINE, ketoconazole, itraconazole, cimetidine, conivaptan, fluconazole, nefazodine, ranolazine, zafirlukast, zileuton

Increase:
hypotension—droperidol

Increase:
CV depression—diazepam

Increase:
fentaNYL effect with other CNS depressants—alcohol, opioids, sedative/hypnotics, antipsychotics, skeletal muscle relaxants, protease inhibitors

Decrease:
fentaNYL effect—CYP3A4 inducers (carBAMazepine, phenytoin, PHENobarbital, rifampin)

Drug/Herb

Increase:
action of fentaNYL—St. John’s wort

Decrease:
effect of fentaNYL—echinacea

Drug/Lab Test

Increase:
amylase, lipase

NURSING CONSIDERATIONS
Assess:

• 
VS after parenteral route; note muscle rigidity, drug history, hepatic/renal function tests

• 
CNS changes: dizziness, drowsiness, hallucinations, euphoria, LOC, pupil reaction

• 
Allergic reactions: rash, urticaria

 

Black Box Warning:

Respiratory dysfunction: respiratory depression,
character, rate, rhythm; notify prescriber if respirations are <10/min

 

Black Box Warning:

Headache/migraine:
ABSTRAL, Actiq, Fentora, Lazanda, Onsolis not to be used for this condition; ABSTRAL, Lazanda not to be used in ER; Duragesic TD not to be used for outpatient surgery patients

 

Black Box Warning:

Apnea, respiratory arrest in opioid-naive patients:
do not use ABSTRAL, Actiq, Duragesic, Fentora, Lazanda, Onsolis; opioid-tolerant patients are those using ≥60 mg/day oral morphine, ≥30 mg/day oxyCODONE PO, 8 mg/day HYDROmorphone, 25 mcg TD fentaNYL/hr

Evaluate:

• 
Therapeutic response: induction of anesthesia, relief of breakthrough cancer pain, general pain relief

• 
Cancer pain, general pain relief

Teach patient/family:

• 
About CNS changes: physical dependence; not to use with alcohol, other CNS depressants

 

Black Box Warning:

Accidental exposure:
Discuss the dangers of children or pets ingesting or coming in contact with product

Transdermal route

 

Black Box Warning:

Ambient temperature:
that excessive heat may increase absorption; do not use with heating pads, electric blankets, heat/tanning lamps, saunas, hot tubs, heated waterbeds, when sunbathing

• 
That excessive perspiration may alter adhesiveness

• 
To dispose of patch by placing sticky sides together and flushing down toilet

• 
That patient may need to clip hair before applying to ensure adhesion

• 
May add first aid tape around the edges if there is a problem with adhesion

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

Other books

Brian's Return by Paulsen, Gary
Lady and the Champ by Katherine Lace
The China Lover by Ian Buruma
The Last Temple by Hank Hanegraaff, Sigmund Brouwer
Exclusive by Eden Bradley
Messenger in the Mist by Aubrie Dionne
A Question of Identity by Anthea Fraser